1. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 6 (June 2016) Authors: Vansteenkiste, Johan F; Cho, Byoung Chul; Vanakesa, Tonu; De Pas, Tommaso; Zielinski, Marcin; Kim, Moon Soo; Jassem, Jacek; Yoshimura, Masahiro; Dahabreh, Jubrail; Nakayama, Haruhiku; Havel, Libor; Kondo, Haruhiko; Mitsudomi, Tetsuya; Zarogoulidis, Konstantinos; Gladkov, Oleg A; Udud, Katalin; Ta... Journal: Lancet oncology Issue: Volume 17:Issue 6(2016:Jun.) Page Start: 822 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial. (2021) Authors: Zemanova, Milada; Cernovska, Marketa; Havel, Libor; Bartek, Tomas; Lukesova, Sarka; Jakesova, Jitka; Vanasek, Jaroslav; Reiterer, Pavel; Kultan, Juraj; Andrasina, Igor; Siskova, Lenka; Koubkova, Leona; Skrickova, Jana; Salajka, Frantisek; Pesek, Milos; Klepetko, Petr; Beniak, Juraj; Fricke, Haral... Journal: Cancer treatment and research communications Issue: Number 28(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 365 Tumor treating fields (TTFields, 150 kHz) concurrent with standard of care treatment for stage 4 non-small cell lung cancer (NSCLC) in phase 3 LUNAR Study. (9th November 2020) Authors: Leal, Ticiana; Bueno, Raphael; Havel, Libor; Ward, Jeffrey Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 365 Tumor treating fields (TTFields, 150 kHz) concurrent with standard of care treatment for stage 4 non-small cell lung cancer (NSCLC) in phase 3 LUNAR Study. (9th November 2020) Authors: Leal, Ticiana; Bueno, Raphael; Havel, Libor; Ward, Jeffrey Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Issue 10212 (23rd November 2019) Authors: Paz-Ares, Luis; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Kazarnowic... Journal: Lancet Issue: Volume 394:Issue 10212(2019) Page Start: 1929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Issue 10212 (23rd November 2019) Authors: Paz-Ares, Luis; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Kazarnowic... Journal: Lancet Issue: Volume 394:Issue 10212(2019) Page Start: 1929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry. Issue 11 (5th October 2020) Authors: Brat, Kristian; Bratova, Monika; Skrickova, Jana; Barinova, Magda; Hurdalkova, Karolina; Pesek, Milos; Havel, Libor; Koubkova, Leona; Hrnciarik, Michal; Krejci, Jana; Fischer, Ondrej; Zemanova, Milada; Coupkova, Helena; Svaton, Martin Journal: Thoracic cancer Issue: Volume 11:Issue 11(2020) Page Start: 3346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial. Issue 10 (October 2022) Authors: O'Brien, Mary; Paz-Ares, Luis; Marreaud, Sandrine; Dafni, Urania; Oselin, Kersti; Havel, Libor; Esteban, Emilio; Isla, Dolores; Martinez-Marti, Alex; Faehling, Martin; Tsuboi, Masahiro; Lee, Jong-Seok; Nakagawa, Kazuhiko; Yang, Jing; Samkari, Ayman; Keller, Steven M; Mauer, Murielle; Jha, Nitish;... Journal: Lancet oncology Issue: Volume 23:Issue 10(2022) Page Start: 1274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. An ocular lesion of unknown aetiology. Issue 2 (June 2021) Authors: Drosslerova, Marie; Cernovska, Marketa; Vasakova, Martina; Havel, Libor Journal: Breathe Issue: Volume 17:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial. Issue 1 (January 2021) Authors: Goldman, Jonathan W; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Garassino, Marina Chiara; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libo... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗